Oculomotor system abnormalities therefore represent additional signs in patients with anti-GAD SPS, or may reflect overlap with oculomotor dysfunction and nystagmus, which has been defined as a distinct clinical entity. Here, GAD1 is linked to pathologic nystagmus.